sodium oxybate

FDA Drug Profile — Lumryz, sodium oxybate, Xyrem

sodium oxybate is listed in the FDA National Drug Code directory with 22 NDC codes, marketed under brand names including Lumryz, sodium oxybate, Xyrem. Available dosage forms: kit, for suspension, extended release, solution.

Drug details

Generic Name
sodium oxybate
Brand Names
Lumryz, sodium oxybate, Xyrem
Application Number
NDA214755
Sponsor
Alkermes, Inc.
NDC Codes
22
Dosage Forms
KIT, FOR SUSPENSION, EXTENDED RELEASE, SOLUTION
Routes
ORAL
Active Ingredients
SODIUM OXYBATE

Indications and Usage

1 INDICATIONS AND USAGE Sodium oxybate oral solution is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy. Pediatric use information is approved for Jazz Pharmaceuticals Inc.’s XYREM (sodium oxybate) Oral Solution. However, due to Jazz Pharmaceuticals Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Sodium oxybate oral solutio n is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy (1).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.